For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Hdt Bio Corp.

USPTO Granted Patents = 18

Trademarks = 1

Forward Citations = 56

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Darrick Carter (18 out of 59 patents)

Steven G Reed (17 out of 146 patents)

Jesse Erasmus (17 out of 18 patents)

4. Malcolm Duthie (17 out of 18 patents)

5. Amit Praful Khandhar (17 out of 23 patents)

6. Bryan J Berube (16 out of 16 patents)

7. Lars Peter Aksel Berglund (3 out of 3 patents)

8. Jacob Freeman Archer (2 out of 3 patents)

9. Jiho Kim (1 out of 2 patents)

10. Steven Gregory Reed (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12485163 - CANCER THERAPY COMPOSITIONS AND USES THEREOF (2025-12-02),

2. 12433957 - Compositions and methods for delivery of RNA (2025-10-07),

3. 12350329 - RNA vaccines against infectious diseases (2025-07-08),

4. 12257299 - SARS-CoV-2 RNA vaccine compositions and methods of use (2025-03-25),

5. 12233160 - Dried nanoparticle compositions (2025-02-25),

6. 12133894 - Compositions and methods for delivery of RNA (2024-11-05),

7. 11896677 - Compositions and methods for delivery of RNA (2024-02-13),

8. 11752218 - Nucleic acid-small diameter and liquid core nanoparticle complexed compositions (2023-09-12),

9. 11679163 - Compositions and methods for delivery of RNA (2023-06-20),

10. 11654200 - Compositions and methods for delivery of RNA (2023-05-23),

11. 11648322 - Compositions and methods for delivery of RNA (2023-05-16),

12. 11648321 - Compositions and methods for delivery of RNA (2023-05-16),

13. 11559584 - Compositions and methods for delivery of RNA (2023-01-24),

14. 11534497 - Compositions and methods for delivery of RNA (2022-12-27),

15. 11458209 - Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen (2022-10-04),

Company Overview

HDT Bio Corp, based in Seattle, WA, specializes in the development of innovative biotherapeutics and vaccine technologies. The company focuses on harnessing advanced immunotherapy approaches to address various diseases, including infectious diseases and cancer. With a commitment to scientific excellence, HDT Bio is dedicated to advancing the field of biotechnology through its research and development efforts, aiming to improve patient outcomes and contribute to global health advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

18 Patents

#113 in Seattle, WA

#385 in Washington

#17,963 in US

#34,217 in the World

Seattle, WA, United States of America

Hdt Bio Corp.

Forward Citations = 56

10 inventors:

Darrick Carter (18 out of 59 patents)

Steven G Reed (17 out of 146 patents)

Jesse Erasmus (17 out of 18 patents)

4. Malcolm Duthie (17 out of 18 patents)

5. Amit Praful Khandhar (17 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hdt Bio Corp.. Retrieved from https://idiyas.com/company/hdt-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…